Cargando…
Friedreich ataxia in COVID-19 time: current impact and future possibilities
COVID-19 outbreak profoundly impacted on daily-life of patients with neurodegenerative diseases, including those with ataxia. Effects on interventional trials have been recently described. Conversely, changes in physical activity programs, which are crucial in care of ataxic patients, have not been...
Autores principales: | Schirinzi, Tommaso, Sancesario, Andrea, Castelli, Enrico, Bertini, Enrico, Vasco, Gessica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787601/ https://www.ncbi.nlm.nih.gov/pubmed/33407890 http://dx.doi.org/10.1186/s40673-020-00127-9 |
Ejemplares similares
-
The Nrf2 induction prevents ferroptosis in Friedreich's Ataxia
por: La Rosa, Piergiorgio, et al.
Publicado: (2020) -
Non-invasive Focal Mechanical Vibrations Delivered by Wearable Devices: An Open-Label Pilot Study in Childhood Ataxia
por: Schirinzi, Tommaso, et al.
Publicado: (2018) -
Nrf2-Inducers Counteract Neurodegeneration in Frataxin-Silenced Motor Neurons: Disclosing New Therapeutic Targets for Friedreich’s Ataxia
por: Petrillo, Sara, et al.
Publicado: (2017) -
One-year outcome of coenzyme Q10 supplementation in ADCK3 ataxia (ARCA2)
por: Schirinzi, Tommaso, et al.
Publicado: (2019) -
Robotic and clinical evaluation of upper limb motor performance in patients with Friedreich’s Ataxia: an observational study
por: Germanotta, Marco, et al.
Publicado: (2015)